Client’s Testimonial:

Thanks for helping us on the filing the I-140. I really appreciate your help.

On November 15th, 2013 We Received Another EB1-A (Alien of Extraordinary Ability) Approval for an Unemployed Researcher in the Fields of Biochemistry and Nanotechnology (Approval Notice)

General Field: Biochemistry and Nanotechnology

Position at the Time of Case Filing: None

National Origin:  India

Service Center: Texas Service Center (TSC)

State of Residence at the Time of Filing:  Georgia

Approval Notice Date: November 15, 2013

Processing Time:  9 days (Premium Processing Service requested)

Case Summary:

The client that we had the opportunity to work with in this case was a researcher from India in the fields of biochemistry and nanotechnology who was not employed at the time her petition was filed. Her doctoral and post-doctoral research had focused on developing and utilizing biosensors and metal nanoclusters for disease detection and diagnostics– topics of study that obviously have great implications for public health and the field of nanotechnology in general.  Her work had resulted in at least 11 peer-reviewed scientific articles, 10 invited peer reviews, a patent, and 6 national and international conference presentations- an extremely productive record compared to that of her colleagues in the shared field of endeavor. At the time that her case was filed, her publications had accumulated at least 442 citations, clearly demonstrating that she had influenced her field and garnered international acclaim.  In addition, she had conducted 17 paper reviews for journals related to the fields of biochemistry and nanotechnology.  The following statement from an international expert showed that her work is important throughout the field, “Although I do not know her personally, I witnessed this presentation and it thoroughly impressed me. [She] was responsible for the conception and creation of electrodes that had the ability to detect uric acid in solution. The electrodes were able to achieve detection by arranging themselves into a monolayer covered the ITO glass electrodes. This technology is coveted by physicians and professionals in the healthcare industry. There are varieties of life-threatening and life-changing conditions that can be treated, but often only if they are detected in their early stages. Some of these conditions include chronic kidney disease, leukemia, gout, and pneumonia. The trait that links these diseases is the presence of uric acid (UA), or urate, in the body. Urate can be found in blood serum and urine, and is the primary end-product of purine metabolism. Detectors that can pick up on the presence of urate can help physicians halt the progression of these diseases, which translates to a large impact on quality of life, survival rates, and quality of care for the countless victims of these diseases, which rank amongst some of the most prevalent in our world.” It was our goal to prove that our client qualified for classification as an Alien of Extraordinary Ability given that she sought to remain in the United States to continue work in the area of biochemistry and nanotechnology, and that her continued research would substantially and prospectively benefit the United States. With the proof and documentation that we provided, her case was approved in just 9 days.

---

North America Immigration Law Group (Chen Immigration Law Associates) is a U.S. immigration law firm dedicated to representing corporations, research institutions, and individuals from all 50 U.S. states regarding I-140 immigration petitions. We specialize in employment-based immigration petition and have a proven record of high success rate for the categories of: EB2-NIW (National Interest Waiver), EB1-A (Alien of Extraordinary Ability), EB1-B (Outstanding Researcher/Professor) and O-1 (Alien of Extraordinary Ability).

Our Ten Thousand I-140 Approvals Provide Unprecedented Insight into the USCIS Adjudication Trend

With more than 16,000 EB-1A, EB-1B, EB-2 NIW and O-1 cases approved, we have first hand information on the manner in which the USCIS adjudicate I-140 cases. As the USCIS has constantly changed its adjudication standards for the EB-1A, EB-1B and EB-2 NIW categories, our firm's huge database of successful cases gives you unprecedented insight to USCIS adjudication trends. We carefully analyze the data for all of our cases and apply the results of our analyses toward giving our clients up-to-date advice and adapting our strategies such that we remain on par with the ever-shifting landscape of immigration law in the U.S. With us, you will always have access to important updates, strategies, and information so that you can make the most informed decisions about your case.

We Have Helped Hundreds and Thousands of Clients with Credentials and Backgrounds Similar to Yours

With our exceedingly large number of successful petitions, no matter what credentials you have, no matter your background and field of expertise, no matter your visa status or nationality, chances are we have helped hundreds or even thousands of clients just like you. Our clients are usually impressed with how well we understand their research and work. Our insight and understanding stems from the fact that we have handled many cases with elements similar to yours already, and this helps us devise the best strategies for each individual petition.

Vast Majority of Clients Came to Us Because of Referrals

For years, our firm has attracted new clients based solely on word of mouth, recommendations, and the positive collaboration experiences shared with them by their friends and family. We take pride in our reputation and work hard to ensure that we provide a green card application experience that our clients are happy to share with their friends and colleagues. That is how our approved cases grew from 600 in 2013 to over 3,500 in 2019.

---

To see more clients’ testimonials and approvals, please refer to:

Client's Testimonials

Approval Notices

To Learn More About Your Options CLICK HERE

---

Copyright © North America Immigration Law Group – WeGreened.com, All Rights Reserved.